Osaic Holdings’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,000
Closed -$16K 7731
2022
Q1
$16K Hold
9,000
﹤0.01% 5860
2021
Q4
$21K Buy
+9,000
New +$25.6K ﹤0.01% 5771

Other funds holding ARDS

Osaic Holdings's ARDS Position: Q2 2022 in Review

Osaic Holdings sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q2 2022, closing a stake of 9,000 shares — an estimated $16K sold.

Osaic Holdings first reported a position in ARDS in Q4 2021 and held it in 2 quarters. The position peaked at $21K in Q4 2021. 19 funds tracked by Wall St. Rank hold ARDS as of Q2 2022.

  • Osaic Holdings reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Osaic Holdings sold 9,000 Aridis Pharmaceuticals Inc. Common Stock shares in Q2 2022, an estimated $16K.
  • Osaic Holdings first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Osaic Holdings's Aridis Pharmaceuticals Inc. Common Stock position peaked at $21K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.